Heart Failure and Reduced Ejection Fraction
Cardiovascular
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
NovartisLCZ696
Impulse DynamicsCardiac Contractility Modulation
Clinical Trials (2)
Total enrollment: 465 patients across 2 trials
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
Start: Aug 2016Est. completion: Jan 2019465 patients
Phase 4Completed
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Start: Nov 2025Est. completion: Apr 2031
N/ARecruiting
Related Jobs in Cardiovascular
Embedded Software and System Test Engineer (H/F)
Cardiawave
Levallois-Perret, France (Hybrid)
Just now
Territory Sales Manager - Iowa / Nebraska
HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
22h ago
From $150K/yr
Ingénieur d'Application Clinique (H/F) Dept. 54, 57, 67, 68, 25, 90
Johnson & Johnson
Issy-les-Moulineaux, France
23h ago
Trainee Technical Specialist
Johnson & Johnson
Leeds, West Yorkshire, United Kingdom
23h ago
Regional Sales Specialist (Orange County / Long Beach, CA) - Johnson & Johnson MedTech, Electrophysiology
Johnson & Johnson
Irvine, California, United States of America
23h ago
$100K - $135K/yr
Clinical Consultant
Johnson & Johnson
North Ryde, New South Wales, Australia
23h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 465 patients
2 companies competing in this space